Treatment with Formestane Alone and in Combination with Aminoglutethimide in Heavily Pretreated Breast Cancer Patients: Clinical and Endocrine Effects

By Geisler J.   Johannessen D.C.   Anker G.   Lonning P.E.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 789-792

Elsevier

Access to resources Recommend Favorite

Quality of Life in Postmenopausal Patients with Breast Cancer after Failure of Tamoxifen: Formestane Versus Megestrol Acetate as Second-line Hormonal Treatment

By Bernhard J.   Castiglione-Gertsch M.   Schmitz S.-F.H.   Thurlimann B.   Cavalli F.   Morant R.   Fey M.F.   Bonnefoi H.   Goldhirsch A.   Hurny C.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 913-920

Elsevier

Access to resources Recommend Favorite

Comorbidity Is a Prognostic Factor in Elderly Patients with Head and Neck Cancer

By Sanabria Alvaro   Carvalho André   Vartanian José   Magrin José   Ikeda Mauro   Kowalski Luiz  

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1449-1457

Springer Publishing Company

Access to resources Recommend Favorite

Formestane Versus Megestrol Acetate in Postmenopausal Breast Cancer Patients After Failure of Tamoxifen: a Phase III Prospective Randomised Cross Over Trial of Second-line Hormonal Treatment (SAKK 2090)

By Swiss Group for Clinical Cancer Research SAKK   Thurlimann B.   Castiglione M.   Hsu-Schmitz S.F.   Cavalli F.   Bonnefoi H.   Fey M.F.   Morant R.   Lohnert T.   Goldhirsch A.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1017-1024

Elsevier

Access to resources Recommend Favorite

Comprehensive geriatric assessment in elderly breast cancer patients

By Taira Naruto  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 183-189

Springer Publishing Company

Access to resources Recommend Favorite